Is Synergy RX legit and worth it?
Synergy RX is a real GLP-1 telehealth provider; we read its site and scored it 2.5/5 in our independent review (High Caution). Biggest plus: Both semaglutide and tirzepatide compounded options available. Watch-out: Founded 2026 β no operational track record whatsoever.
Scorecard: strongest in Access (3.5/5) and Patient Protection (3.4/5); weakest in Reputation (1.0/5) and Trust & Transparency (2.0/5).

Medications
Semaglutide, Tirzepatide (as entered 11 April 2026; capture date not recorded)
Monthly Cost
$199 – $399 (as entered 11 April 2026; capture date not recorded)
Speed to Start
Slow: 2 to 3 Weeks
Trustpilot
Not yet rated (as recorded April 2026; not re-checked)
Prices and medications in this review are as entered in our research on 11 April 2026 (the date we captured them was not recorded), unless a line is marked otherwise, and have not been re-checked since. Note added 13 October 2026.
Corrected 14 October 2026: this review previously gave a Better Business Bureau rating or listing status. We kept no record of where it came from, so it has been removed. Trustpilot figures in this review are as recorded in April 2026 and have not been re-checked.
Est. 2026
About Synergy RX
Synergy RX is among the newest entrants in the compounded GLP-1 market, founded in 2026. The platform offers compounded semaglutide and tirzepatide via subcutaneous injection, with monthly pricing ranging from $199 to $399.
As a brand-new platform, Synergy RX has no Trustpilot reviews and no publicly verifiable track record. This isn’t unusual for a just-launched telehealth company, but it means patients have zero independent data to evaluate the actual patient experience. Trust and compliance transparency is rated low.
The clinical program is minimal β no lab testing, no dietitian access, and low ongoing support. Onboarding is notably slow at 2 to 3 weeks, which is below average for the telehealth GLP-1 market where many competitors offer same-day or next-day prescriptions. Cost transparency is rated medium.
The compounded-only model with unknown CoA testing status and undisclosed pharmacy partners adds sourcing concerns. For a platform with no external validation to offset these gaps, the risk profile is elevated compared to established competitors at similar price points.
Patients considering Synergy RX should weigh the complete absence of reputation data against the availability of more established alternatives that have been independently reviewed and rated by patients.
Synergy RX GLP-1 Medications
At a Glance
Medications Offered
Semaglutide, Tirzepatide (as entered 11 April 2026; capture date not recorded)
Compounded
Cost & Insurance
- Monthly: $199 – $399 (as entered 11 April 2026; capture date not recorded)
- 6-month estimate: $1200 – $2400 (as entered 11 April 2026; capture date not recorded)
- Insurance: No
- Self-pay: Yes
Clinical Features
- Lab testing: No
- Dietitian access: No
Delivery & Access
- Format: Subcutaneous
- Nationwide telehealth: Yes
- Speed: Slow: 2 to 3 Weeks
- Spanish-speaking providers: Not available
What the Synergy Rx Intake Looks Like
We walked through Synergy Rx’s full GLP-1 intake ourselves, from the BMI calculator through two condition multi-selects to the approve-first-charge checkout. Here’s what an actual prospective patient encounters before being prescribed β including a notable FDA-black-box gap and a contradictory consultation-fee disclosure.
/ 10
Notably weaker than peer compounded providers. Synergy Rx asks two condition multi-selects with a suicidal-thoughts checkbox and the cancer 5-year-remission threshold, but MTC and MEN2 family history are not asked anywhere in the visible flow β a significant FDA-black-box gap. There is also no allergy screen, no eating-disorder check, no medication list, and no BP/HR reading.
/ 10
Low. Anonymous-friendly questionnaire β name, email, and phone aren’t collected until after every clinical question. Approve-first-charge applies at the plan-selection step, but the consultation-fee disclosure contradicts itself ($80 on one screen, $59 on another) and the brand identity is muddled (RxActivate appears at checkout instead of Synergy Rx).
The 5 Stages
Clinical Safety Screens Performed
Medullary Thyroid Cancer (MTC) and Multiple Endocrine Neoplasia type 2 (MEN2) family history are the GLP-1 class FDA black-box warning, and most compounded providers in our catalog ask about them as a dedicated checkbox or a multi-select item. Synergy Rx does not ask about MTC or MEN2 anywhere in the visible 16-screen flow β neither personal history nor family history. The intake also doesn’t include pancreatitis, gastroparesis, anorexia or bulimia, an opiate or alcohol screen, an allergy screen of any kind, or a medication list (current meds is a Yes/No only). Sex is collected as a binary Male / Female only, and no actual blood pressure or heart-rate reading is captured.
The TeleHealth-visit fee surfaces in two contradictory amounts. The billing-cycle screen states: “There is an $80 TeleHealth visit cost regardless of whether I receive medication.” The Care Validate disclosure on the final payment page reads: “You will be charged $59 for your initial TeleHealth visit.” Patients should not assume either amount is the binding figure β both quotes are visible in the same flow.
The Care Validate copy on the final screen also references “RxActivate remains your primary service provider” rather than “Synergy Rx,” suggesting RxActivate is the underlying entity operating multiple consumer brands on the same Care Validate billing infrastructure. Patients may see CAREVALIDATE or RxActivate on card statements rather than Synergy Rx.
Source: GLP-1.Reviews editorial walkthrough on April 30, 2026. We completed every screen of the Synergy Rx weight-loss intake using a representative GLP-1 candidate persona and stopped before submitting any payment information.
Opens synergyrx.co in a new tab.
Start your GLP-1 weight loss journey with Synergy RX today
Medical Disclaimer: This review is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that should only be used under the supervision of a licensed healthcare provider. Individual results may vary.
Editorial Independence: GLP-1.Reviews maintains full editorial independence. We read providers’ own pages and public records and publish what we find, with the date we checked.
Corrected 13 October 2026: this review showed a “Verified Provider” badge and said our scores were “based on verified data and standardized criteria”. Neither described a check we had done, so both have been removed.













